カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の二重抗体薬市場予測2023-2029：レモバブ、BLINCYTO、その他

【英語タイトル】Double Barreled Antibodies Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8480）・商品コード：MMG23LY8480
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：76
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の二重抗体薬市場規模と予測を収録しています。・世界の二重抗体薬市場：売上、2018年-2023年、2024年-2029年
・世界の二重抗体薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の二重抗体薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「レモバブ」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

二重抗体薬のグローバル主要企業は、Amgen Inc.、 F. Hoffman La Roche Ltd.、 AbbVie Inc.、 OncoMed Pharmaceuticals, Inc.、 Glenmark Pharmaceuticals Limited、 Xencor, Inc.、 MacroGenics, Inc.、 Aptevo Therapeutics Inc.、 Ligand Pharmaceuticals, Inc.、 Regeneron Pharmaceuticals, Inc.、 Fresenius SE & Co. KGaA、 Merus N.V.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、二重抗体薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の二重抗体薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の二重抗体薬市場：タイプ別市場シェア、2022年
・レモバブ、BLINCYTO、その他

世界の二重抗体薬市場：用途別、2018年-2023年、2024年-2029年
世界の二重抗体薬市場：用途別市場シェア、2022年
・肺がん、脳がん、肝臓がん、その他

世界の二重抗体薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の二重抗体薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における二重抗体薬のグローバル売上、2018年-2023年
・主要企業における二重抗体薬のグローバル売上シェア、2022年
・主要企業における二重抗体薬のグローバル販売量、2018年-2023年
・主要企業における二重抗体薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Amgen Inc.、 F. Hoffman La Roche Ltd.、 AbbVie Inc.、 OncoMed Pharmaceuticals, Inc.、 Glenmark Pharmaceuticals Limited、 Xencor, Inc.、 MacroGenics, Inc.、 Aptevo Therapeutics Inc.、 Ligand Pharmaceuticals, Inc.、 Regeneron Pharmaceuticals, Inc.、 Fresenius SE & Co. KGaA、 Merus N.V.

*************************************************************

・調査・分析レポートの概要
二重抗体薬市場の定義
市場セグメント
世界の二重抗体薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の二重抗体薬市場規模
世界の二重抗体薬市場規模：2022年 VS 2029年
世界の二重抗体薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの二重抗体薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の二重抗体薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：レモバブ、BLINCYTO、その他
二重抗体薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：肺がん、脳がん、肝臓がん、その他
二重抗体薬の用途別グローバル売上・予測

・地域別市場分析
地域別二重抗体薬市場規模 2022年と2029年
地域別二重抗体薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Amgen Inc.、 F. Hoffman La Roche Ltd.、 AbbVie Inc.、 OncoMed Pharmaceuticals, Inc.、 Glenmark Pharmaceuticals Limited、 Xencor, Inc.、 MacroGenics, Inc.、 Aptevo Therapeutics Inc.、 Ligand Pharmaceuticals, Inc.、 Regeneron Pharmaceuticals, Inc.、 Fresenius SE & Co. KGaA、 Merus N.V.
...

This report aims to provide a comprehensive presentation of the global market for Double Barreled Antibodies Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Double Barreled Antibodies Drug. This report contains market size and forecasts of Double Barreled Antibodies Drug in global, including the following market information:
Global Double Barreled Antibodies Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Double Barreled Antibodies Drug Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Double Barreled Antibodies Drug companies in 2022 (%)
The global Double Barreled Antibodies Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Removab Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Double Barreled Antibodies Drug include Amgen Inc., F. Hoffman La Roche Ltd., AbbVie Inc., OncoMed Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Xencor, Inc., MacroGenics, Inc., Aptevo Therapeutics Inc. and Ligand Pharmaceuticals, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Double Barreled Antibodies Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Double Barreled Antibodies Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Double Barreled Antibodies Drug Market Segment Percentages, by Type, 2022 (%)
Removab
BLINCYTO
Others
Global Double Barreled Antibodies Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Double Barreled Antibodies Drug Market Segment Percentages, by Application, 2022 (%)
Lung Cancer
Brain Cancer
Liver Cancer
Others
Global Double Barreled Antibodies Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Double Barreled Antibodies Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Double Barreled Antibodies Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Double Barreled Antibodies Drug revenues share in global market, 2022 (%)
Key companies Double Barreled Antibodies Drug sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Double Barreled Antibodies Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen Inc.
F. Hoffman La Roche Ltd.
AbbVie Inc.
OncoMed Pharmaceuticals, Inc.
Glenmark Pharmaceuticals Limited
Xencor, Inc.
MacroGenics, Inc.
Aptevo Therapeutics Inc.
Ligand Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Fresenius SE & Co. KGaA
Merus N.V.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Double Barreled Antibodies Drug, market overview.
Chapter 2: Global Double Barreled Antibodies Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Double Barreled Antibodies Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Double Barreled Antibodies Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Double Barreled Antibodies Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Double Barreled Antibodies Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Double Barreled Antibodies Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Double Barreled Antibodies Drug Overall Market Size
2.1 Global Double Barreled Antibodies Drug Market Size: 2022 VS 2029
2.2 Global Double Barreled Antibodies Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Double Barreled Antibodies Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Double Barreled Antibodies Drug Players in Global Market
3.2 Top Global Double Barreled Antibodies Drug Companies Ranked by Revenue
3.3 Global Double Barreled Antibodies Drug Revenue by Companies
3.4 Global Double Barreled Antibodies Drug Sales by Companies
3.5 Global Double Barreled Antibodies Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Double Barreled Antibodies Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Double Barreled Antibodies Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Double Barreled Antibodies Drug Players in Global Market
3.8.1 List of Global Tier 1 Double Barreled Antibodies Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Double Barreled Antibodies Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Double Barreled Antibodies Drug Market Size Markets, 2022 & 2029
4.1.2 Removab
4.1.3 BLINCYTO
4.1.4 Others
4.2 By Type – Global Double Barreled Antibodies Drug Revenue & Forecasts
4.2.1 By Type – Global Double Barreled Antibodies Drug Revenue, 2018-2023
4.2.2 By Type – Global Double Barreled Antibodies Drug Revenue, 2024-2029
4.2.3 By Type – Global Double Barreled Antibodies Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Double Barreled Antibodies Drug Sales & Forecasts
4.3.1 By Type – Global Double Barreled Antibodies Drug Sales, 2018-2023
4.3.2 By Type – Global Double Barreled Antibodies Drug Sales, 2024-2029
4.3.3 By Type – Global Double Barreled Antibodies Drug Sales Market Share, 2018-2029
4.4 By Type – Global Double Barreled Antibodies Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Double Barreled Antibodies Drug Market Size, 2022 & 2029
5.1.2 Lung Cancer
5.1.3 Brain Cancer
5.1.4 Liver Cancer
5.1.5 Others
5.2 By Application – Global Double Barreled Antibodies Drug Revenue & Forecasts
5.2.1 By Application – Global Double Barreled Antibodies Drug Revenue, 2018-2023
5.2.2 By Application – Global Double Barreled Antibodies Drug Revenue, 2024-2029
5.2.3 By Application – Global Double Barreled Antibodies Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Double Barreled Antibodies Drug Sales & Forecasts
5.3.1 By Application – Global Double Barreled Antibodies Drug Sales, 2018-2023
5.3.2 By Application – Global Double Barreled Antibodies Drug Sales, 2024-2029
5.3.3 By Application – Global Double Barreled Antibodies Drug Sales Market Share, 2018-2029
5.4 By Application – Global Double Barreled Antibodies Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Double Barreled Antibodies Drug Market Size, 2022 & 2029
6.2 By Region – Global Double Barreled Antibodies Drug Revenue & Forecasts
6.2.1 By Region – Global Double Barreled Antibodies Drug Revenue, 2018-2023
6.2.2 By Region – Global Double Barreled Antibodies Drug Revenue, 2024-2029
6.2.3 By Region – Global Double Barreled Antibodies Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Double Barreled Antibodies Drug Sales & Forecasts
6.3.1 By Region – Global Double Barreled Antibodies Drug Sales, 2018-2023
6.3.2 By Region – Global Double Barreled Antibodies Drug Sales, 2024-2029
6.3.3 By Region – Global Double Barreled Antibodies Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Double Barreled Antibodies Drug Revenue, 2018-2029
6.4.2 By Country – North America Double Barreled Antibodies Drug Sales, 2018-2029
6.4.3 US Double Barreled Antibodies Drug Market Size, 2018-2029
6.4.4 Canada Double Barreled Antibodies Drug Market Size, 2018-2029
6.4.5 Mexico Double Barreled Antibodies Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Double Barreled Antibodies Drug Revenue, 2018-2029
6.5.2 By Country – Europe Double Barreled Antibodies Drug Sales, 2018-2029
6.5.3 Germany Double Barreled Antibodies Drug Market Size, 2018-2029
6.5.4 France Double Barreled Antibodies Drug Market Size, 2018-2029
6.5.5 U.K. Double Barreled Antibodies Drug Market Size, 2018-2029
6.5.6 Italy Double Barreled Antibodies Drug Market Size, 2018-2029
6.5.7 Russia Double Barreled Antibodies Drug Market Size, 2018-2029
6.5.8 Nordic Countries Double Barreled Antibodies Drug Market Size, 2018-2029
6.5.9 Benelux Double Barreled Antibodies Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Double Barreled Antibodies Drug Revenue, 2018-2029
6.6.2 By Region – Asia Double Barreled Antibodies Drug Sales, 2018-2029
6.6.3 China Double Barreled Antibodies Drug Market Size, 2018-2029
6.6.4 Japan Double Barreled Antibodies Drug Market Size, 2018-2029
6.6.5 South Korea Double Barreled Antibodies Drug Market Size, 2018-2029
6.6.6 Southeast Asia Double Barreled Antibodies Drug Market Size, 2018-2029
6.6.7 India Double Barreled Antibodies Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Double Barreled Antibodies Drug Revenue, 2018-2029
6.7.2 By Country – South America Double Barreled Antibodies Drug Sales, 2018-2029
6.7.3 Brazil Double Barreled Antibodies Drug Market Size, 2018-2029
6.7.4 Argentina Double Barreled Antibodies Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Double Barreled Antibodies Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Double Barreled Antibodies Drug Sales, 2018-2029
6.8.3 Turkey Double Barreled Antibodies Drug Market Size, 2018-2029
6.8.4 Israel Double Barreled Antibodies Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Double Barreled Antibodies Drug Market Size, 2018-2029
6.8.6 UAE Double Barreled Antibodies Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen Inc.
7.1.1 Amgen Inc. Company Summary
7.1.2 Amgen Inc. Business Overview
7.1.3 Amgen Inc. Double Barreled Antibodies Drug Major Product Offerings
7.1.4 Amgen Inc. Double Barreled Antibodies Drug Sales and Revenue in Global (2018-2023)
7.1.5 Amgen Inc. Key News & Latest Developments
7.2 F. Hoffman La Roche Ltd.
7.2.1 F. Hoffman La Roche Ltd. Company Summary
7.2.2 F. Hoffman La Roche Ltd. Business Overview
7.2.3 F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Major Product Offerings
7.2.4 F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Sales and Revenue in Global (2018-2023)
7.2.5 F. Hoffman La Roche Ltd. Key News & Latest Developments
7.3 AbbVie Inc.
7.3.1 AbbVie Inc. Company Summary
7.3.2 AbbVie Inc. Business Overview
7.3.3 AbbVie Inc. Double Barreled Antibodies Drug Major Product Offerings
7.3.4 AbbVie Inc. Double Barreled Antibodies Drug Sales and Revenue in Global (2018-2023)
7.3.5 AbbVie Inc. Key News & Latest Developments
7.4 OncoMed Pharmaceuticals, Inc.
7.4.1 OncoMed Pharmaceuticals, Inc. Company Summary
7.4.2 OncoMed Pharmaceuticals, Inc. Business Overview
7.4.3 OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Major Product Offerings
7.4.4 OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales and Revenue in Global (2018-2023)
7.4.5 OncoMed Pharmaceuticals, Inc. Key News & Latest Developments
7.5 Glenmark Pharmaceuticals Limited
7.5.1 Glenmark Pharmaceuticals Limited Company Summary
7.5.2 Glenmark Pharmaceuticals Limited Business Overview
7.5.3 Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Major Product Offerings
7.5.4 Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Sales and Revenue in Global (2018-2023)
7.5.5 Glenmark Pharmaceuticals Limited Key News & Latest Developments
7.6 Xencor, Inc.
7.6.1 Xencor, Inc. Company Summary
7.6.2 Xencor, Inc. Business Overview
7.6.3 Xencor, Inc. Double Barreled Antibodies Drug Major Product Offerings
7.6.4 Xencor, Inc. Double Barreled Antibodies Drug Sales and Revenue in Global (2018-2023)
7.6.5 Xencor, Inc. Key News & Latest Developments
7.7 MacroGenics, Inc.
7.7.1 MacroGenics, Inc. Company Summary
7.7.2 MacroGenics, Inc. Business Overview
7.7.3 MacroGenics, Inc. Double Barreled Antibodies Drug Major Product Offerings
7.7.4 MacroGenics, Inc. Double Barreled Antibodies Drug Sales and Revenue in Global (2018-2023)
7.7.5 MacroGenics, Inc. Key News & Latest Developments
7.8 Aptevo Therapeutics Inc.
7.8.1 Aptevo Therapeutics Inc. Company Summary
7.8.2 Aptevo Therapeutics Inc. Business Overview
7.8.3 Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Major Product Offerings
7.8.4 Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Sales and Revenue in Global (2018-2023)
7.8.5 Aptevo Therapeutics Inc. Key News & Latest Developments
7.9 Ligand Pharmaceuticals, Inc.
7.9.1 Ligand Pharmaceuticals, Inc. Company Summary
7.9.2 Ligand Pharmaceuticals, Inc. Business Overview
7.9.3 Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Major Product Offerings
7.9.4 Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales and Revenue in Global (2018-2023)
7.9.5 Ligand Pharmaceuticals, Inc. Key News & Latest Developments
7.10 Regeneron Pharmaceuticals, Inc.
7.10.1 Regeneron Pharmaceuticals, Inc. Company Summary
7.10.2 Regeneron Pharmaceuticals, Inc. Business Overview
7.10.3 Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Major Product Offerings
7.10.4 Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales and Revenue in Global (2018-2023)
7.10.5 Regeneron Pharmaceuticals, Inc. Key News & Latest Developments
7.11 Fresenius SE & Co. KGaA
7.11.1 Fresenius SE & Co. KGaA Company Summary
7.11.2 Fresenius SE & Co. KGaA Double Barreled Antibodies Drug Business Overview
7.11.3 Fresenius SE & Co. KGaA Double Barreled Antibodies Drug Major Product Offerings
7.11.4 Fresenius SE & Co. KGaA Double Barreled Antibodies Drug Sales and Revenue in Global (2018-2023)
7.11.5 Fresenius SE & Co. KGaA Key News & Latest Developments
7.12 Merus N.V.
7.12.1 Merus N.V. Company Summary
7.12.2 Merus N.V. Double Barreled Antibodies Drug Business Overview
7.12.3 Merus N.V. Double Barreled Antibodies Drug Major Product Offerings
7.12.4 Merus N.V. Double Barreled Antibodies Drug Sales and Revenue in Global (2018-2023)
7.12.5 Merus N.V. Key News & Latest Developments
8 Global Double Barreled Antibodies Drug Production Capacity, Analysis
8.1 Global Double Barreled Antibodies Drug Production Capacity, 2018-2029
8.2 Double Barreled Antibodies Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Double Barreled Antibodies Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Double Barreled Antibodies Drug Supply Chain Analysis
10.1 Double Barreled Antibodies Drug Industry Value Chain
10.2 Double Barreled Antibodies Drug Upstream Market
10.3 Double Barreled Antibodies Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Double Barreled Antibodies Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Double Barreled Antibodies Drug in Global Market
Table 2. Top Double Barreled Antibodies Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Double Barreled Antibodies Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Double Barreled Antibodies Drug Revenue Share by Companies, 2018-2023
Table 5. Global Double Barreled Antibodies Drug Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Double Barreled Antibodies Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Double Barreled Antibodies Drug Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Double Barreled Antibodies Drug Product Type
Table 9. List of Global Tier 1 Double Barreled Antibodies Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Double Barreled Antibodies Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Double Barreled Antibodies Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Double Barreled Antibodies Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Double Barreled Antibodies Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Double Barreled Antibodies Drug Sales (K Pcs), 2018-2023
Table 15. By Type - Global Double Barreled Antibodies Drug Sales (K Pcs), 2024-2029
Table 16. By Application – Global Double Barreled Antibodies Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Double Barreled Antibodies Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Double Barreled Antibodies Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Double Barreled Antibodies Drug Sales (K Pcs), 2018-2023
Table 20. By Application - Global Double Barreled Antibodies Drug Sales (K Pcs), 2024-2029
Table 21. By Region – Global Double Barreled Antibodies Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Double Barreled Antibodies Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Double Barreled Antibodies Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Double Barreled Antibodies Drug Sales (K Pcs), 2018-2023
Table 25. By Region - Global Double Barreled Antibodies Drug Sales (K Pcs), 2024-2029
Table 26. By Country - North America Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Double Barreled Antibodies Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Double Barreled Antibodies Drug Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Double Barreled Antibodies Drug Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Double Barreled Antibodies Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Double Barreled Antibodies Drug Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Double Barreled Antibodies Drug Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Double Barreled Antibodies Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Double Barreled Antibodies Drug Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Double Barreled Antibodies Drug Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Double Barreled Antibodies Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Double Barreled Antibodies Drug Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Double Barreled Antibodies Drug Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Double Barreled Antibodies Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Double Barreled Antibodies Drug Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Double Barreled Antibodies Drug Sales, (K Pcs), 2024-2029
Table 46. Amgen Inc. Company Summary
Table 47. Amgen Inc. Double Barreled Antibodies Drug Product Offerings
Table 48. Amgen Inc. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Amgen Inc. Key News & Latest Developments
Table 50. F. Hoffman La Roche Ltd. Company Summary
Table 51. F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Product Offerings
Table 52. F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. F. Hoffman La Roche Ltd. Key News & Latest Developments
Table 54. AbbVie Inc. Company Summary
Table 55. AbbVie Inc. Double Barreled Antibodies Drug Product Offerings
Table 56. AbbVie Inc. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. AbbVie Inc. Key News & Latest Developments
Table 58. OncoMed Pharmaceuticals, Inc. Company Summary
Table 59. OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Product Offerings
Table 60. OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. OncoMed Pharmaceuticals, Inc. Key News & Latest Developments
Table 62. Glenmark Pharmaceuticals Limited Company Summary
Table 63. Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Product Offerings
Table 64. Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Glenmark Pharmaceuticals Limited Key News & Latest Developments
Table 66. Xencor, Inc. Company Summary
Table 67. Xencor, Inc. Double Barreled Antibodies Drug Product Offerings
Table 68. Xencor, Inc. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Xencor, Inc. Key News & Latest Developments
Table 70. MacroGenics, Inc. Company Summary
Table 71. MacroGenics, Inc. Double Barreled Antibodies Drug Product Offerings
Table 72. MacroGenics, Inc. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. MacroGenics, Inc. Key News & Latest Developments
Table 74. Aptevo Therapeutics Inc. Company Summary
Table 75. Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Product Offerings
Table 76. Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Aptevo Therapeutics Inc. Key News & Latest Developments
Table 78. Ligand Pharmaceuticals, Inc. Company Summary
Table 79. Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Product Offerings
Table 80. Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Ligand Pharmaceuticals, Inc. Key News & Latest Developments
Table 82. Regeneron Pharmaceuticals, Inc. Company Summary
Table 83. Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Product Offerings
Table 84. Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Regeneron Pharmaceuticals, Inc. Key News & Latest Developments
Table 86. Fresenius SE & Co. KGaA Company Summary
Table 87. Fresenius SE & Co. KGaA Double Barreled Antibodies Drug Product Offerings
Table 88. Fresenius SE & Co. KGaA Double Barreled Antibodies Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. Fresenius SE & Co. KGaA Key News & Latest Developments
Table 90. Merus N.V. Company Summary
Table 91. Merus N.V. Double Barreled Antibodies Drug Product Offerings
Table 92. Merus N.V. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. Merus N.V. Key News & Latest Developments
Table 94. Double Barreled Antibodies Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 95. Global Double Barreled Antibodies Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Double Barreled Antibodies Drug Production by Region, 2018-2023 (K Pcs)
Table 97. Global Double Barreled Antibodies Drug Production by Region, 2024-2029 (K Pcs)
Table 98. Double Barreled Antibodies Drug Market Opportunities & Trends in Global Market
Table 99. Double Barreled Antibodies Drug Market Drivers in Global Market
Table 100. Double Barreled Antibodies Drug Market Restraints in Global Market
Table 101. Double Barreled Antibodies Drug Raw Materials
Table 102. Double Barreled Antibodies Drug Raw Materials Suppliers in Global Market
Table 103. Typical Double Barreled Antibodies Drug Downstream
Table 104. Double Barreled Antibodies Drug Downstream Clients in Global Market
Table 105. Double Barreled Antibodies Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Double Barreled Antibodies Drug Segment by Type in 2022
Figure 2. Double Barreled Antibodies Drug Segment by Application in 2022
Figure 3. Global Double Barreled Antibodies Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Double Barreled Antibodies Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Double Barreled Antibodies Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Double Barreled Antibodies Drug Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Double Barreled Antibodies Drug Revenue in 2022
Figure 9. By Type - Global Double Barreled Antibodies Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Double Barreled Antibodies Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Double Barreled Antibodies Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Double Barreled Antibodies Drug Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Double Barreled Antibodies Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Double Barreled Antibodies Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Double Barreled Antibodies Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Double Barreled Antibodies Drug Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Double Barreled Antibodies Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Double Barreled Antibodies Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Double Barreled Antibodies Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Double Barreled Antibodies Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Double Barreled Antibodies Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Double Barreled Antibodies Drug Sales Market Share, 2018-2029
Figure 23. US Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Double Barreled Antibodies Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Double Barreled Antibodies Drug Sales Market Share, 2018-2029
Figure 28. Germany Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Double Barreled Antibodies Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Double Barreled Antibodies Drug Sales Market Share, 2018-2029
Figure 37. China Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Double Barreled Antibodies Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Double Barreled Antibodies Drug Sales Market Share, 2018-2029
Figure 44. Brazil Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Double Barreled Antibodies Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Double Barreled Antibodies Drug Sales Market Share, 2018-2029
Figure 48. Turkey Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Double Barreled Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Double Barreled Antibodies Drug Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Double Barreled Antibodies Drug by Region, 2022 VS 2029
Figure 54. Double Barreled Antibodies Drug Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の二重抗体薬市場予測2023-2029：レモバブ、BLINCYTO、その他] (コード：MMG23LY8480)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の二重抗体薬市場予測2023-2029：レモバブ、BLINCYTO、その他]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のベクター化抗体市場予測2023-2029：アデノ随伴ウイルス（AAV）ベクター、エレクトロポレーション、脂質ナノ粒子（LNP）、その他
  • 世界の細胞結合型二重特異性抗体市場予測2023-2029：T細胞エンゲージャー、NK細胞エンゲージャー
  • 世界の高シュウ酸尿症一次治療薬市場予測2023-2029：ALLN-230、DCR-PHXC、ALN-GO1、その他
  • 世界の一次抗体市場予測2023-2029：ポリクローナル、モノクローナル
  • 世界の運動促進薬市場予測2023-2029：メトクロプラミド、ドンペリドン、シサプリド、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆